NZ508439A - Novel endometriosis-associated gene - Google Patents

Novel endometriosis-associated gene

Info

Publication number
NZ508439A
NZ508439A NZ508439A NZ50843999A NZ508439A NZ 508439 A NZ508439 A NZ 508439A NZ 508439 A NZ508439 A NZ 508439A NZ 50843999 A NZ50843999 A NZ 50843999A NZ 508439 A NZ508439 A NZ 508439A
Authority
NZ
New Zealand
Prior art keywords
endometriosis
novel
associated gene
nucleotide sequence
nucleotide
Prior art date
Application number
NZ508439A
Other languages
English (en)
Inventor
Silvia Kotzian
Heike Handrow-Metzmacher
Original Assignee
Starzinski Powitz Anna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starzinski Powitz Anna filed Critical Starzinski Powitz Anna
Publication of NZ508439A publication Critical patent/NZ508439A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ508439A 1998-05-29 1999-05-28 Novel endometriosis-associated gene NZ508439A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen
PCT/EP1999/003716 WO1999063079A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen

Publications (1)

Publication Number Publication Date
NZ508439A true NZ508439A (en) 2004-02-27

Family

ID=7869409

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ508439A NZ508439A (en) 1998-05-29 1999-05-28 Novel endometriosis-associated gene

Country Status (9)

Country Link
US (1) US6586569B1 (https=)
EP (1) EP1080195A1 (https=)
JP (1) JP2002517193A (https=)
CN (1) CN1307636A (https=)
AU (1) AU765515B2 (https=)
CA (1) CA2329527A1 (https=)
DE (1) DE19824230A1 (https=)
NZ (1) NZ508439A (https=)
WO (1) WO1999063079A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290218B8 (en) * 2000-02-25 2007-10-03 Siemens Medical Solutions Diagnostics Endometriosis-related markers and uses thereof
EP1801236B1 (en) * 2000-02-25 2009-11-18 Siemens Healthcare Diagnostics Inc. Endometriosis related markers and uses thereof
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CN112180099B (zh) * 2020-09-15 2022-07-29 江南大学附属医院 子宫内膜异位症血清标志物的应用
CN113512584B (zh) * 2021-06-24 2022-03-25 南京鼓楼医院 Pbk/topk在诊断和治疗薄型内膜疾病中的应用
CN120721966A (zh) * 2025-07-16 2025-09-30 杭州市第一人民医院(西湖大学附属杭州市第一人民医院) 丙酮酸羧化酶在诊断和治疗子宫内膜异位症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005268A1 (en) * 1992-09-04 1994-03-17 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
AU6960694A (en) * 1993-05-28 1994-12-20 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
CA2179168A1 (en) * 1993-12-17 1995-06-22 Douglas A. Kniss Antisense oligonucleotides to suppress eicosanoid formation
WO1996040720A1 (en) * 1995-06-07 1996-12-19 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben
CA2265470A1 (en) * 1996-09-06 1998-03-12 Osteometer Biotech A/S Biochemical markers of the human endometrium

Also Published As

Publication number Publication date
CA2329527A1 (en) 1999-12-09
CN1307636A (zh) 2001-08-08
AU765515B2 (en) 2003-09-18
JP2002517193A (ja) 2002-06-18
WO1999063079A1 (de) 1999-12-09
US6586569B1 (en) 2003-07-01
US20030109018A1 (en) 2003-06-12
EP1080195A1 (de) 2001-03-07
AU4502499A (en) 1999-12-20
DE19824230A1 (de) 1999-12-02

Similar Documents

Publication Publication Date Title
NZ508439A (en) Novel endometriosis-associated gene
GB9922124D0 (en) Phosphodiesterase enzymes
EE9900581A (xx) LAG-3 pleissimisteisendid
CA2166685A1 (en) An enzyme with protease activity
ES2154624T1 (es) Regulacion de la expresion de la quinolato fosforribosil transferasa.
EP1034302A4 (en) DE NOVO OR "UNIVERSAL" SEQUENCING ARRAY
BG105899A (en) Fucosyl transferase gene
IL102765A (en) Reagents and methods to detect and determine mycobacterium nucleic acids
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
EP1037999A4 (en) POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS
DK0461045T3 (https=)
EP0769553A4 (en) DNA FRAGMENT, RECOMBINANT VECTOR THAT CONTAINS IT AND METHOD FOR EXPRESSING FOREIGN GENES WITH ITS USE
GB0020331D0 (en) Enzyme
EP1108786A4 (en) NEW COLLECTIN
AU8447098A (en) Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
CA2045839A1 (en) Cloned n-methylhydantoinase
ZA99236B (en) Orotidine-5'-phosphate decarboxylase gene, gene construct comprising this gene and its use.
AU782261C (en) Novel glycosyltransferase genes
WO1997035993A3 (en) PSA positive regulating (PSAR) sequences and uses thereof
SE9801098D0 (sv) Receptors
WO2001005986A3 (en) Mites-like element and transcriptional activation element
BG105460A (en) Prv-1 gene and the use thereof
CA2261964A1 (en) New tumor suppressor gene and the protein coded thereby, methods of production and use thereof
EP1724351A3 (en) Human Kallikrein-like genes
ATE458043T1 (de) Mn-gen und -protein

Legal Events

Date Code Title Description
PSEA Patent sealed